Pharmacokinetics/pharmacodynamics of inhaled insulin investigated in different patient populations Sep. 17, 2002
GLP-1 and its analogue LY-315902 inhibit intestinal motility and reduce plasma somatostatin Sep. 17, 2002
Recent studies support Pyridorin as a potentially important advance in diabetic nephropathy Sep. 17, 2002
TAK-475: synthesis and preliminary pharmacological profile of a new squalene synthase inhibitor Sep. 16, 2002
New Drug Associates licenses lipoprotein remnant targeting technology from U. of Alabama Sep. 16, 2002
RSS